VESUGEN INJECTOR PEN 3ML

Vesugen (Lys-Glu-Asp / KED): The Targeted Vascular Endothelial Bioregulator for Cardiovascular Renewal, Microcirculation, and Anti-Aging — Now Available in the UAE

Vesugen is a new type of short-chain bioregulator developed by Dr. Vladimir Khavinson and his team at the St. Petersburg Institute of Bioregulation and Gerontology. Vesugen is referred to as KED (lysine-glutamic acid-aspartic acid). Developed using amino acids found in protein structures present in blood vessel walls, Vesugen works specifically in the lining of blood vessels through-out the entire body. As an Epigenetic Regulator Vesugen has demonstrated to interact with Chromatin in Endothelial Cells to restore normal Gene Expression, restoring pathways of gene expression which are suppressed due to Age Related Degradation, Oxidative Stress, Inflammation, and Metabolic Dysfunction. A few key examples of how Vesugen accomplishes this is by restoring the expression of Endothelial Nitric Oxide Synthase (eNOS); Modulating Adhesion Molecules such as Vascular Cell Adhesion Molecule 1 (VCAM-1) and Intercellular Adhesion Molecule 1 (ICAM-1); Regulating Endothelin-1; Increasing Connexins (proteins involved in inter-cellular communication); and increasing the proliferation marker Ki-67. All these functions work together to assist in maintaining the Quiescent State of Endothelium; Improve Vascular Tone; Reduce Inflammation; and Increase Tissue Repair.

Due to its specific action on the endothelial cells lining the interior surface of all blood vessels throughout the body, Vesugen is ideal for use in Research to Investigate Endothelial Dysfunction — a condition commonly associated with Hypertension; Atherosclerosis; Microvascular Disease; Coronary Artery Disease; Peripheral Artery Disease; and Age Related Reduced Compliance of Blood Vessels. Additionally, Vesugen can be used as part of Studies related to Neuro-Vascular Health; Wound Healing; Micro-Circulation; Metabolic Syndrome; and Geroprotection — studies designed to delay the onset of senescence related loss of healthy vascular function.

Each of our Premium Vesugen Injector Pens contain a highly concentrated solution of 3ml high purity (>99%) peptide synthesized according to GMP standards. Each Pen is designed to provide easy access for Sub-Cutaneous Administration of a precise dose of peptide directly into the vascular tissue. The Bio-Availability to vascular tissues and ease-of-administration provides for excellent performance in Cardio-Vascular, Endothelial and Longevity Research Protocols. Additionally, each Pen Format allows researchers to easily conduct either Short-Term Exploratory Studies or Longer Cyclic Investigations without having to worry about degradation of the Peptide.

Below, explore six key research-supported potential benefits of Vesugen, grounded in mechanistic preclinical data, molecular studies, and Khavinson bioregulator science.

1. Restoration of Endothelial Function and Nitric Oxide Bioavailability
Vesugen has been shown to normalize eNOS mRNA levels in the endothelial cell line EA.hy926, thereby enhancing NO production which is critical for relaxation of blood vessels, prevention of platelets from clumping together, and suppression of inflammation. Additionally, by restoring flow-mediated dilation and vascular reactivity in both age-damaged as well as diseased artery models, Vesugen may serve as a potential agent to prevent the continued loss of endothelial function that occurs with aging and chronic cardiovascular disease.

2. Enhancement of Microcirculation and Tissue Perfusion
The effects of Vesugen on peripheral microcirculation can be understood as improvement in microvascular blood flow and oxygenation (oxygen/nutrient) of peripheral tissues/organs due to a reduction in the degree of endothelial swelling, improved pericyte function and optimized capillary integrity. As such, it is expected that these improvements will assist in reversing hypoxic conditions and edema related to poor microvascular perfusion.

3. Modulation of Atherosclerosis Development and Plaque Progression
Vesugen inhibits monocyte transmigration by lowering the levels of endothelial cell adhesive proteins (ICAM-1, VCAM-1) thereby decreasing the first two phases of forming an atherosclerotic plaque. In addition to this, Vesugen increases the normal expression of endothelin-1. This is a reduction in signaling that promotes atherosclerosis. Early pre-clinical research has demonstrated decreased plaque development along with increased structural integrity of the vascular wall, which suggests that Vesugen could be useful in future prevention studies of atherosclerosis; studies on restenosis and other forms of lipid-driven vascular disease.

4. Support for Blood Pressure Homeostasis and Vascular Tone
By rebalancing vasodilator (nitric oxide) with vasoconstrictors, Vesugen is able to help regulate blood vessel diameter and peripheral resistance. Studies involving animal models of hypertension have shown significant and long-term reduction in all blood pressure related variables after treatment of hypertension. The potential for this compound may include being an effective tool in studying essential hypertension, as well as a tool to study the effects of vascular stiffness on overall health and as a means to understand how various aspects of cardiovascular disease can be treated through integrative medicine.

5. Reversal of Vascular Aging and Arterial Stiffness
VESUGEN is shown to normalize the ratio of collagen-to-elastin that occurs with normal aging as well as decrease levels of Advanced Glycosylation End Products (AGE’s) and activate a group of proteins called sirtuins (SIRT1). VESUGEN has been demonstrated to help maintain arterial flexibility and youthful appearance of the blood vessels. Pre-clinical longitudinal studies have demonstrated maintained vascular flexibility and function in aged animal models demonstrating its potential for longevity, anti-aging and geroprotection within vascular related studies.

6. Neurovascular Protection and Broader Systemic Benefits
The beneficial effects of improved endothelial health and the maintenance of an intact blood-brain-barrier contribute to the protective properties and enhanced cerebral perfusion that are attributed to Vesugen. Additionally, through modulating connexin expression, which can promote cellular communication; and by reducing vascular oxidative stress and inflammation; Vesugen will also be useful as a tool in various studies that investigate neurovascular, cognitive, metabolic, or multiple organ systems with respect to maintaining vascular integrity.

Why Choose Our Vesugen Injector Pen?

The Vesugen we use comes from well-established contract manufacturers that have experience with Khavinson peptide synthesis. We also test every batch of Vesugen through third-party testing for purity, potency, identity, sterility and stability. Each lot is tested according to the high standards of reproducibility needed for sensitive cardiac and endothelial research.

Our precision engineered injector pen format allows for easy subcutaneous injection with accurate dosing control, little waste and long term storage stability. For this reason it is an ideal format for consistent daily or cyclic protocols in laboratories or other investigative environments.

The Vesugen product represents the power and tissue specificity of the Khavinson bioregulator sciences. By focusing its activity on the endothelial cell type, researchers can utilize a powerful epigenetic tool to study vascular renewal, protect against heart disease and understand the mechanisms involved in maintaining good health as one ages.

Please always contact your qualified medical professional, Institutional Review Board (IRB) or Research Ethics Committee prior to implementing any research protocol.

Important Note: This product is intended strictly for research and laboratory use only. It is not for personal consumption, human or animal therapeutic use, or any clinical application. Please consult and fully comply with all local regulations in the UAE before purchasing or handling.